InfuSystem Holdings, Inc (INFU)

Name: InfuSystem Holdings, Inc (INFU) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001337013 · NYSE · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, InfuSystem Holdings, Inc reported revenue of $143.44M. Revenue grew 6.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $143.34M.

Key ratios (year ended 2025-12-31)

56.0%

Gross margin

8.3%

Operating margin

4.6%

Net margin

11.6%

Return on year-end equity

6.4%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$143.34M	$143.44M	$134.86M	$125.78M	$109.91M	$102.38M	$97.39M	$81.11M	$67.14M	$71.08M	$70.50M
Cost of Revenue	$60.98M	$63.14M	$64.46M	$62.68M	$49.35M	$43.85M	$38.63M	$34.23M	$27.57M	$18.37M	$16.21M
Gross Profit	$82.35M	$80.30M	$70.40M	$63.11M	$60.56M	$58.54M	$58.76M	$46.88M	$39.57M	$43.36M	$44.74M
Operating Income	$13.27M	$11.92M	$6.89M	$4.09M	$1.65M	$2.82M	$8.83M	$3.52M	$415.0K	-$3.81M	$974.0K
Depreciation & Amortization	$13.06M	$13.29M	$12.50M	$12.51M	$13.36M	$14.62M	$14.03M	$12.34M	$11.31M	n/a	n/a
EBITDA	$26.33M	$25.21M	$19.39M	$16.60M	$15.01M	$17.45M	$22.85M	$15.87M	$11.72M	n/a	n/a
Net Income	$8.54M	$6.63M	$2.35M	$872.0K	$18.0K	$1.42M	$17.33M	$1.36M	-$1.09M	-$20.71M	-$222.0K
EPS (Diluted)	n/a	$0.31	$0.11	$0.04	$0.00	$0.06	$0.80	$0.07	-$0.05	-$0.91	-$0.01
Total Assets	$97.70M	$100.56M	$103.61M	$102.92M	$99.39M	$97.59M	$96.99M	$79.22M	$64.07M	$68.88M	$96.34M
Total Liabilities	$38.55M	$43.23M	$46.09M	$50.61M	$51.38M	$49.31M	$56.24M	$56.89M	$43.63M	$37.93M	$45.66M
Long-Term Debt	$20.42M	$19.62M	$23.86M	$29.10M	$33.16M	$33.10M	$38.80M	$38.38M	$33.74M	$28.39M	$31.89M
Shareholders' Equity	$59.15M	$57.33M	$57.53M	$52.30M	$48.00M	$48.27M	$40.75M	$22.33M	$20.44M	$30.95M	$50.69M
Cash & Equivalents	$964.0K	$3.19M	$527.0K	$231.0K	$165.0K	$186.0K	$9.65M	$2.65M	$4.32M	$3.47M	$3.40M
Operating Cash Flow	$23.37M	$24.41M	$20.46M	$11.22M	$17.52M	$18.32M	$20.28M	$13.88M	$11.39M	$7.72M	$7.91M
Capital Expenditures	$460.0K	$560.0K	$1.09M	$1.02M	$982.0K	$980.0K	$1.09M	$2.93M	$281.0K	$104.0K	$168.0K
Free Cash Flow	$22.91M	$23.85M	$19.37M	$10.20M	$16.54M	$17.34M	$19.19M	$10.95M	$11.11M	$7.61M	$7.74M
Share Repurchases	$7.83M	$9.87M	$1.18M	$153.0K	$5.46M	$560.0K	$0	$0	$10.39M	n/a	$75.0K
Shares Outstanding	19.91M	20.21M	21.27M	21.20M	20.78M	20.70M	20.30M	19.88M	19.58M	22.78M	22.67M
Weighted Average Diluted Shares	n/a	21.10M	21.71M	21.65M	21.55M	22.05M	21.72M	20.84M	21.42M	22.74M	22.62M
EPS (Basic)	n/a	$0.32	$0.11	$0.04	$0.00	$0.07	$0.86	$0.07	-$0.05	-$0.91	-$0.01

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView